BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

541 related articles for article (PubMed ID: 12861075)

  • 1. The two faces of transforming growth factor beta in carcinogenesis.
    Roberts AB; Wakefield LM
    Proc Natl Acad Sci U S A; 2003 Jul; 100(15):8621-3. PubMed ID: 12861075
    [No Abstract]   [Full Text] [Related]  

  • 2. Medicine. Tracing the steps of metastasis, cancer's menacing ballet.
    Couzin J
    Science; 2003 Feb; 299(5609):1002-6. PubMed ID: 12586919
    [No Abstract]   [Full Text] [Related]  

  • 3. Mouse models of transforming growth factor beta impact in breast development and cancer.
    Serra R; Crowley MR
    Endocr Relat Cancer; 2005 Dec; 12(4):749-60. PubMed ID: 16322320
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The RUNX genes: gain or loss of function in cancer.
    Blyth K; Cameron ER; Neil JC
    Nat Rev Cancer; 2005 May; 5(5):376-87. PubMed ID: 15864279
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transcriptional cooperation between the transforming growth factor-beta and Wnt pathways in mammary and intestinal tumorigenesis.
    Labbé E; Lock L; Letamendia A; Gorska AE; Gryfe R; Gallinger S; Moses HL; Attisano L
    Cancer Res; 2007 Jan; 67(1):75-84. PubMed ID: 17210685
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The role of TGF-beta in the EMT of tumor cells].
    Liu DZ; Wang YS; Ji AG
    Sheng Li Ke Xue Jin Zhan; 2011 Dec; 42(6):463-6. PubMed ID: 22363989
    [No Abstract]   [Full Text] [Related]  

  • 7. Multidirectional tumor-suppressive activity of AIMP2/p38 and the enhanced susceptibility of AIMP2 heterozygous mice to carcinogenesis.
    Choi JW; Um JY; Kundu JK; Surh YJ; Kim S
    Carcinogenesis; 2009 Sep; 30(9):1638-44. PubMed ID: 19622630
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of Smad7 expression on metastasis of mouse mammary carcinoma JygMC(A) cells.
    Azuma H; Ehata S; Miyazaki H; Watabe T; Maruyama O; Imamura T; Sakamoto T; Kiyama S; Kiyama Y; Ubai T; Inamoto T; Takahara S; Itoh Y; Otsuki Y; Katsuoka Y; Miyazono K; Horie S
    J Natl Cancer Inst; 2005 Dec; 97(23):1734-46. PubMed ID: 16333029
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transforming growth factor-beta regulates mammary carcinoma cell survival and interaction with the adjacent microenvironment.
    Bierie B; Stover DG; Abel TW; Chytil A; Gorska AE; Aakre M; Forrester E; Yang L; Wagner KU; Moses HL
    Cancer Res; 2008 Mar; 68(6):1809-19. PubMed ID: 18339861
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Concordant epigenetic silencing of transforming growth factor-beta signaling pathway genes occurs early in breast carcinogenesis.
    Hinshelwood RA; Huschtscha LI; Melki J; Stirzaker C; Abdipranoto A; Vissel B; Ravasi T; Wells CA; Hume DA; Reddel RR; Clark SJ
    Cancer Res; 2007 Dec; 67(24):11517-27. PubMed ID: 18089780
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Transforming growth factor-betas: smad signaling and roles in physiopathology].
    Javelaud D; Mauviel A
    Pathol Biol (Paris); 2004 Feb; 52(1):50-4. PubMed ID: 14761714
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Roles of TGFbeta in metastasis.
    Padua D; Massagué J
    Cell Res; 2009 Jan; 19(1):89-102. PubMed ID: 19050696
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Smad3 is key to TGF-beta-mediated epithelial-to-mesenchymal transition, fibrosis, tumor suppression and metastasis.
    Roberts AB; Tian F; Byfield SD; Stuelten C; Ooshima A; Saika S; Flanders KC
    Cytokine Growth Factor Rev; 2006; 17(1-2):19-27. PubMed ID: 16290023
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metastasis suppressors genes in cancer.
    Stafford LJ; Vaidya KS; Welch DR
    Int J Biochem Cell Biol; 2008; 40(5):874-91. PubMed ID: 18280770
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Smad-binding defective mutant of transforming growth factor beta type I receptor enhances tumorigenesis but suppresses metastasis of breast cancer cell lines.
    Tian F; Byfield SD; Parks WT; Stuelten CH; Nemani D; Zhang YE; Roberts AB
    Cancer Res; 2004 Jul; 64(13):4523-30. PubMed ID: 15231662
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mammalian transforming growth factor-betas: Smad signaling and physio-pathological roles.
    Javelaud D; Mauviel A
    Int J Biochem Cell Biol; 2004 Jul; 36(7):1161-5. PubMed ID: 15109563
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metastasis tumor antigen family proteins during breast cancer progression and metastasis in a reliable mouse model for human breast cancer.
    Zhang H; Stephens LC; Kumar R
    Clin Cancer Res; 2006 Mar; 12(5):1479-86. PubMed ID: 16533771
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pro-metastasis function of TGFbeta mediated by the Smad pathway.
    Kang Y
    J Cell Biochem; 2006 Aug; 98(6):1380-90. PubMed ID: 16598746
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of TGFbeta signaling in cancer therapy.
    Arteaga CL
    Curr Opin Genet Dev; 2006 Feb; 16(1):30-7. PubMed ID: 16377175
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of TGF-beta in oncogenesis.
    Weller M; Wick W; Platten M
    Microsc Res Tech; 2001 Feb; 52(4):353. PubMed ID: 11170293
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 28.